MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 30 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,255,402 | +5.3% | 1,695,291 | -3.2% | 0.00% | +50.0% |
Q2 2023 | $4,990,829 | +73165.3% | 1,751,168 | +1.3% | 0.00% | -50.0% |
Q1 2023 | $6,812 | -21.6% | 1,729,022 | -21.2% | 0.00% | 0.0% |
Q4 2022 | $8,692 | -99.9% | 2,195,029 | +114.3% | 0.00% | -20.0% |
Q3 2022 | $9,413,000 | +16.7% | 1,024,298 | -24.6% | 0.01% | 0.0% |
Q2 2022 | $8,069,000 | -2.5% | 1,358,362 | +5.4% | 0.01% | +25.0% |
Q1 2022 | $8,275,000 | +28.2% | 1,288,923 | +30.7% | 0.00% | +33.3% |
Q4 2021 | $6,457,000 | +62.6% | 985,867 | +41.8% | 0.00% | +50.0% |
Q3 2021 | $3,970,000 | +0.5% | 695,241 | -3.3% | 0.00% | 0.0% |
Q2 2021 | $3,952,000 | -4.9% | 718,630 | +0.1% | 0.00% | -33.3% |
Q1 2021 | $4,156,000 | -15.7% | 717,797 | -2.4% | 0.00% | 0.0% |
Q4 2020 | $4,930,000 | +118.8% | 735,786 | +139.1% | 0.00% | 0.0% |
Q3 2020 | $2,253,000 | +538.2% | 307,754 | +60.4% | 0.00% | +200.0% |
Q1 2020 | $353,000 | -25.2% | 191,858 | +550.5% | 0.00% | 0.0% |
Q4 2019 | $472,000 | +15.1% | 29,494 | +24.4% | 0.00% | 0.0% |
Q3 2019 | $410,000 | -55.9% | 23,704 | -30.7% | 0.00% | 0.0% |
Q2 2019 | $929,000 | – | 34,199 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management III, LLC | 2,066,529 | $38,541,000 | 23.79% |
Novo Holdings A/S | 2,674,470 | $49,879,000 | 8.54% |
ACUTA CAPITAL PARTNERS, LLC | 369,500 | $6,891,000 | 4.97% |
RTW INVESTMENTS, LP | 3,521,856 | $63,819,000 | 3.80% |
Boxer Capital, LLC | 1,102,194 | $20,556,000 | 1.49% |
Ghost Tree Capital, LLC | 235,000 | $4,383,000 | 1.12% |
VHCP Management II, LLC | 148,560 | $2,771,000 | 1.06% |
Tekla Capital Management LLC | 46,940 | $812,000 | 0.04% |
Baker Brothers Advisors | 266,667 | $4,973,000 | 0.03% |
Zimmer Partners, LP | 160,000 | $2,984,000 | 0.03% |